lobbying_activities: 1311694
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1311694 | 3b1df5bd-6552-4e40-9fcb-6d0c4067ac6c | Q3 | COMPASS CONSULTING GROUP, LLC | 295031 | AMYLIN PHARMACEUTICALS, INC. | 2012 | third_quarter | PHA | General FDA, pharmaceutical, and Medicare issues. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-10-19T14:17:41.313000-04:00 |